Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Heart failure (HF) with Reduced Ejection Fraction (HFrEF) – Market Insight, Epidemiology, and Market Forecast – 2034
... report delivers an in-depth understanding of the Heart failure (HF) with Reduced Ejection Fraction (HFrEF), historical and forecasted epidemiology as well as the Heart failure (HF) with Reduced Ejection Fraction (HFrEF) market trends in the ... Read More
-
Chronic Heart Failure – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Chronic Heart Failure market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Chronic Heart Failure market report provides current ... Read More
-
Global Active Pharmaceutical Ingredients (API) Market Report by Drug Type (Innovative, Generic), Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Application (Cardiovascular Diseases, Oncology, Central Nervous System and Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Other Applications), Regions and Company Analysis 2024-2032
... Other Applications), Regions and Company Analysis 2024-2032 Active Pharmaceutical Ingredients Market is envisioned at US$ 212.12 billion in 2023 and is anticipated to attain US$ 377.05 billion via 2032, growing at a CAGR of % ... Read More
-
Advanced Heart Failure – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Advanced Heart Failure market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Advanced Heart Failure market report provides current ... Read More
-
Atrial Fibrillation – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Atrial Fibrillation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Atrial Fibrillation market report provides current treatment practices, emerging drugs, Atrial ... Read More
-
Coronary Occlusion – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Coronary Occlusion market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Coronary Occlusion market report provides current treatment practices, emerging drugs, Coronary ... Read More
-
No Option Refractory Disabling Angina (NORDA) – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the No Option Refractory Disabling Angina (NORDA), historical and forecasted epidemiology as well as the No Option Refractory Disabling Angina (NORDA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Cardiac Insufficiency – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Cardiac Insufficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cardiac Insufficiency market report provides current treatment practices, emerging drugs, Cardiac ... Read More
-
End-Stage Coronary Artery Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... Coronary Artery Disease, historical and forecasted epidemiology as well as the End-Stage Coronary Artery Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The End-Stage Coronary Artery ... Read More
-
Non-ST Segment Elevation Acute Coronary Syndromes (NSTE ACSs) – Market Insight, Epidemiology, and Market Forecast – 2034
... report delivers an in-depth understanding of the Non-ST Segment Elevation Acute Coronary Syndromes (NSTE ACSs), historical and forecasted epidemiology as well as the Non-ST Segment Elevation Acute Coronary Syndromes (NSTE ACSs) market trends in the ... Read More
-
Cardiac Amyloidosis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Cardiac Amyloidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cardiac Amyloidosis market report provides current treatment practices, emerging drugs, Cardiac ... Read More
-
Left Ventricular Dysfunction – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Left Ventricular Dysfunction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Left Ventricular Dysfunction market report provides current ... Read More
-
Acute Heart failure (AHF) – Market Insight, Epidemiology, and Market Forecast – 2034
... Heart failure (AHF), historical and forecasted epidemiology as well as the Acute Heart failure (AHF) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Acute Heart failure ... Read More
-
Angina (Angina Pectoris) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Angina (Angina Pectoris) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Angina (Angina Pectoris) market report provides current ... Read More
-
Postmyocardial Infarction Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Postmyocardial Infarction Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Postmyocardial Infarction Syndrome market report provides current ... Read More
-
Post-Cardiac Arrest Syndrome (PCAS) – Market Insight, Epidemiology, and Market Forecast – 2034
... Arrest Syndrome (PCAS), historical and forecasted epidemiology as well as the Post-Cardiac Arrest Syndrome (PCAS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Post-Cardiac Arrest Syndrome ... Read More
-
Hypertrophic Cardiomyopathy (HCM) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Hypertrophic Cardiomyopathy (HCM) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Hypertrophic Cardiomyopathy (HCM) market report provides current ... Read More
-
Cardiac Arrythmia – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Cardiac Arrythmia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cardiac Arrythmia market report provides current treatment practices, emerging drugs, Cardiac ... Read More
-
Dyslipidemia – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Dyslipidemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Dyslipidemia market report provides current treatment practices, emerging drugs, Dyslipidemia market share of the individual ... Read More
-
Ischemic Stroke – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Ischemic Stroke market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Ischemic Stroke market report provides current treatment practices, emerging drugs, Ischemic ... Read More
-
Heart Failure – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Heart Failure market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Heart Failure market report provides current treatment practices, emerging drugs, Heart ... Read More
-
BNP And NTproBNP Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (BNP (Brain Natriuretic Peptide), NT-proBNP (N-terminal Pro-B-Type Natriuretic Peptide), By Location of Testing (Point Of Care Testing, Laboratory Testing), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Others), By Region and Competition, 2019-2029F
... By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Others), By Region and Competition, 2019-2029F Global BNP And NT-proBNP Market was valued at USD 1840.56 Million in 2023 and is anticipated to project ... Read More
-
North America Cardiac Markers Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Reagents and Kits, and Analyzers), Biomarker Type (Troponin, Creatine Kinase-MB, Myoglobin, B-Type Natriuretic Peptide, and Others), Indication (Congestive Heart Failure, Myocradial Infraction, Acute Coronary Syndrome, and Others), End User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing Facilities, and Others), and Country (US, Canada, Mexico)
... Myoglobin, B-Type Natriuretic Peptide, and Others), Indication (Congestive Heart Failure, Myocradial Infraction, Acute Coronary Syndrome, and Others), End User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing Facilities, and Others), and Country (US, Canada, Mexico) The global North ... Read More
-
RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033
... By End User: Hospitals; Research Laboratories; Pharmaceutical And Biotechnology CompaniesCovering: Ionis Pharmaceuticals; Alnylam Pharmaceuticals; Sarepta Therapeutics; Jazz Pharmaceuticals; Novartis RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033 from The Business Research ... Read More
-
Contract Research and Manufacturing Service (CRAMS) Market in India 2024-2028
... 10.8% during the forecast period. The report on the contract research and manufacturing service (CRAMS) market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor ... Read More
Research Assistance
